GO
Loading...

Humana Inc

More

  • WASHINGTON, Feb 17- Five Republican state governors say they will not rescue a crucial part of Obamacare if it is struck down by the Supreme Court, underlining the prospect for a chaotic aftermath to a ruling that could force millions of Americans to pay much more for coverage or lose their health insurance. In response to Reuters' queries, spokespeople for the...

  • Insurers are benefiting from increased number of patients, aided by an expansion of Medicaid, a federal health insurance program for lower-income people that is administered by the states, under Obamacare. WellCare members under the Medicaid health plans increased 31 percent to 2.3 million in the fourth quarter ended Dec. 31, helped by additions in Florida,...

  • The busier-than-normal flu season has resulted in some U.S. insurers such as Centene Corp and Humana Inc flagging cost concern. We are disappointed with our fourth quarter earnings due to the effect of the early and more severe flu season on our Medicaid business, "WellCare Chief Executive Kenneth Burdick said in a statement on Wednesday.

  • Lightning Round: This stock needs to split up Tuesday, 10 Feb 2015 | 7:31 PM ET
    Mad Money Lightning Round

    Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Feb 4- U.S. health insurer Humana Inc reported a lower-than- expected fourth-quarter profit as it spent more on new hepatitis C treatments and flu season expenses increased, but it said those and other costs are behind it and predicted a better 2015.. Humana shares, which were off slightly before a company conference call began, rose 1.9 percent to $151.39 in...

  • Early movers: ODP, SPLS, GM, MRK, ADP & more Wednesday, 4 Feb 2015 | 8:06 AM ET
    A trader works on the floor of the New York Stock Exchange, Oct. 31, 2014.

    Some of the names on the move ahead of the open.

  • Feb 4- U.S. health insurer Humana Inc reported a lower-than- expected fourth-quarter profit as it spent more on hepatitis C treatments and flu season expenses increased. Humana's net income rose to $145 million, or 94 cents per share, in the quarter ended Dec. 31 compared with a loss of $30 million, or 19 cents per share, a year earlier, when it set aside funds for...

  • Health insurer Humana reports pretax profit Wednesday, 4 Feb 2015 | 6:18 AM ET

    Feb 4- U.S. health insurer Humana Inc posted a pretax profit for the fourth quarter, compared with a loss a year earlier, reflecting a rise in individual Medicare Advantage memberships. The company reported pretax income of $287 million, or 94 cents per share, compared with a loss of $49 million, or 19 cents per share, a year earlier when it set aside funds for long-term...

  • Stocks close up sharply, boosted by Greece and oil Monday, 2 Feb 2015 | 4:00 PM ET
    Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed sharply higher on encouraging news from the Eurozone and stronger oil prices.

  • Drugmaker AbbVie beats as Humira sales rise Friday, 30 Jan 2015 | 11:34 AM ET
    AbbVie facility in Ireland

    U.S. drugmaker AbbVie's revenue beat analysts' estimates for the fourth straight quarter as sales of arthritis drug Humira jumped nearly 11 percent.

  • Jan 30- U.S. drugmaker AbbVie Inc's revenue beat analysts' estimates for the fourth straight quarter as sales of arthritis drug Humira jumped nearly 11 percent. Excluding the charge and other special items, AbbVie earned 89 cents per share. Sales of Humira, which AbbVie inherited from Abbott Laboratories in 2013, rose to $3.36 billion in the fourth quarter ended...

  • Jan 26- Pharmacy benefits manager EnvisionRx said on Monday it reached an agreement to provide its customers with Gilead Sciences Inc's hepatitis C drugs on an exclusive basis, the latest Gilead victory in a market share battle with AbbVie over their new treatments for the liver destroying virus. EnvisionRx said Gilead's Sovaldi and its newer two-drug...

  • Midday movers: Exxon Mobil, Amazon, Boeing & more Wednesday, 21 Jan 2015 | 1:07 PM ET
    Exchange Place NYSE

    Some of Wednesday's midday movers:

  • *Disney falls after results, Salix plummets. "Any kind of change in how the healthcare law is interpreted is going to affect healthcare stocks, probably insurers first," said Kim Forrest, senior equity research analyst at Fort Pitt Capital Group in Pittsburgh. Hospital operator Tenet Healthcare fell 6.5 percent to $47.85 while managed care facilities operator...

  • US STOCKS-Wall St flat as healthcare offsets energy Friday, 7 Nov 2014 | 2:41 PM ET

    NEW YORK, Nov 7- U.S. stocks were little changed on Friday as gains in energy shares were offset by falling healthcare stocks, in the wake of October payrolls data that indicated economic resilience in the face of slowing global demand. The unemployment rate fell to 5.8 percent, the lowest since July 2008, even as more people entered the labor force.

  • Humana says profit fell on investments, drug costs Friday, 7 Nov 2014 | 11:11 AM ET

    Humana said that profit fell as it invested in the Obamacare health exchanges and health contracts, and paid for costly hepatitis C treatments.

  • US stock futures turn lower after payrolls report Friday, 7 Nov 2014 | 8:59 AM ET
    New York Stock Exchange NYSE

    Nonfarm payrolls will be the big event on Wall Street on Friday, with stock index futures ticking higher in anticipation.

  • Early Movers: HD, GPS, NKE, KING, SHLD & more Friday, 7 Nov 2014 | 8:06 AM ET

    Some of the names on the move ahead of the open.

  • Nov 7- U.S. health insurer Humana Inc on Friday reported a lower third-quarter profit that missed Wall Street estimates as it paid for costly hepatitis C treatments and invested in the Obamacare health insurance exchanges and state-based health contracts. Humana also said relatively flat premiums and stable networks next year should help increase its...

  • Nov 7- Health insurer Humana Inc said on Friday that third-quarter profit fell as it invested in the Obamacare health insurance exchanges and state-based health contracts, and paid for costly hepatitis C treatments. For 2015, the company said it expected earnings of $8.50 to $9.00 a share, up from its lowered expectations of $7.40 to $7.60 for 2014. In 2015 it...